• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    India Globalization Capital Inc (NY: IGC )

    0.4700 +0.0100 (+2.17%)
    Streaming Delayed Price Updated: 9:57 AM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 161,125
    Open 0.4600
    Bid (Size) 0.4607 (1)
    Ask (Size) 0.4700 (182)
    Prev. Close 0.4600
    Today's Range 0.4600 - 0.4749
    52wk Range 0.2501 - 0.9099
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target
    From IGC Pharma, Inc.
    Via Business Wire
    BioMedNewsBreaks — IGC Pharma Inc.’s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence

    Performance

    YTD
    +70.29%
    +70.29%
    1 Month
    +13.66%
    +13.66%
    3 Month
    -19.86%
    -19.86%
    6 Month
    +70.91%
    +70.91%
    1 Year
    +33.52%
    +33.52%

    More News

    Read More
    Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile
    From IGC Pharma, Inc.
    Via Business Wire
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Positive Data from TGR-63 Preclinical Studies
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Financial Report for Fiscal Year
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease
    From IGC Pharma, Inc.
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024
    Via InvestorPlace
    IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
    From IGC Pharma, Inc.
    Via Business Wire
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets
    From IGC Pharma, Inc.
    Via Business Wire
    Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected
    Via Benzinga
    Topics Cannabis Regulatory Compliance
    Exposures Cannabis Legal Regulatory
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol
    From IGC Pharma, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1
    From IGC Pharma Inc.
    Via Business Wire
    BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    IGC Pharma to Attend BIO International Convention 2024
    From IGC Pharma Inc.
    Via Business Wire
    6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
    Via News Direct
    6.7 Million Americans Live With Alzheimer’s – IGC Pharma Believes They Deserve Treatment Options Without Black Box Warnings
    Via TheNewswire.com
    Topics Cannabis
    Exposures Cannabis Product Safety
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.